Company news

Anixa Biosciences, Inc. news in 2020

Anixa Biosciences, Inc.'s news releases, calls and decks from 2020, newest first.

View company

Anixa Biosciences and Cleveland Clinic Announce FDA Clearance to Initiate Clinical Trial of Breast Cancer Vaccine

December 20, 2020

Anixa Biosciences Announces Licensing Agreement with Cleveland Clinic for Ovarian Cancer Vaccine Technology

November 30, 2020

Anixa Biosciences and Cleveland Clinic File IND Application for Breast Cancer Vaccine

November 22, 2020

Anixa and OntoChem Announce Identification of Additional Covid-19 Compounds

August 12, 2020

Anixa Biosciences Breast Cancer Vaccine Technology Nearing FDA Submission

July 27, 2020

Anixa Biosciences Announces Change to Virtual Format for 2020 Annual Meeting of Stockholders

July 19, 2020

Anixa and OntoChem Announce Completion of Initial Screening Program and Identification of Additional Covid-19 Compounds

July 5, 2020

Anixa Announces Strategic Program Realignment Focused on Advancement of its Therapeutic and Vaccine Pipeline

July 1, 2020

Anixa Biosciences and OntoChem Announce Discovery of First Covid-19 Therapeutic Candidate

May 3, 2020

Anixa Biosciences Announces Publication of Peer-Reviewed Journal Article in Biomarker Insights Highlighting Cchek™ Liquid Biopsy Technology

April 22, 2020

Anixa Biosciences and OntoChem Announce Collaboration to Develop Novel COVID-19 Therapeutics

April 19, 2020

Anixa Biosciences Announces Presentation at AI and Big Data in Cancer Conference

March 1, 2020

Anixa Biosciences and Moffitt Cancer Center Announce Completion of Viral Vector Reformulation for CAR-T Program

February 11, 2020

Anixa Biosciences Announces Presentation at AACR Liquid Biopsies Conference

January 5, 2020

Decks in 2020